PT Brigit Biofarmaka Teknologi Tbk (ISX:OBAT) Current Deferred Revenue: Rp0.00 Mil (As of . 20)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is PT Brigit Biofarmaka Teknologi Tbk Current Deferred Revenue?

PT Brigit Biofarmaka Teknologi Tbk ISX:OBAT -0.82% Current Deferred Revenue is Rp0.00 Mil as of . 20. The stock has 1 warning sign investors should review.

Current Deferred Revenue represents collections of cash or other assets related to revenue producing activity for which revenue has not yet been recognized. Generally, an entity records deferred revenue when it receives consideration from a customer before achieving certain criteria that must be met for revenue to be recognized in conformity with GAAP. It can be either current or non-current item. Also called unearned revenue.

PT Brigit Biofarmaka Teknologi Tbk's current deferred revenue for the quarter that ended in . 20 was Rp0.00 Mil.

PT Brigit Biofarmaka Teknologi Tbk Current Deferred Revenue Related Terms

PT Brigit Biofarmaka Teknologi Tbk Current Deferred Revenue Historical Data

* Premium members only.

The historical data trend for PT Brigit Biofarmaka Teknologi Tbk's Current Deferred Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

PT Brigit Biofarmaka Teknologi Tbk Current Deferred Revenue Chart

PT Brigit Biofarmaka Teknologi Tbk Annual Data
Trend
Current Deferred Revenue

PT Brigit Biofarmaka Teknologi Tbk Semi-Annual Data
Current Deferred Revenue
What does a Current Deferred Revenue of Rp0.00 Mil mean?
PT Brigit Biofarmaka Teknologi Tbk (ISX:OBAT) has a Current Deferred Revenue of Rp0.00 Mil as of . 20. Current Deferred Revenue records the total amount of cash received for unfinished services. View historical data on PT Brigit Biofarmaka Teknologi Tbk and its competitors.
Is PT Brigit Biofarmaka Teknologi Tbk's Current Deferred Revenue too high?
PT Brigit Biofarmaka Teknologi Tbk's current Current Deferred Revenue is Rp0.00 Mil.
How does PT Brigit Biofarmaka Teknologi Tbk's Current Deferred Revenue compare to KHC and GIS?
PT Brigit Biofarmaka Teknologi Tbk's Current Deferred Revenue of Rp0.00 Mil can be compared against companies in the Consumer Packaged Goods industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Current Deferred Revenue for a Consumer Packaged Goods company?
A good Current Deferred Revenue depends on the Consumer Packaged Goods industry context. However, Current Deferred Revenue should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Current Deferred Revenue mean?
A high Current Deferred Revenue can signal that a stock is expensive relative to its fundamentals. Current Deferred Revenue records the total amount of cash received for unfinished services. View historical data on PT Brigit Biofarmaka Teknologi Tbk and its competitors. PT Brigit Biofarmaka Teknologi Tbk's current Current Deferred Revenue is Rp0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PT Brigit Biofarmaka Teknologi Tbk stock overvalued right now?
PT Brigit Biofarmaka Teknologi Tbk (ISX:OBAT) has a current Current Deferred Revenue of Rp0.00 Mil. The current Current Deferred Revenue is Rp0.00 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Current Deferred Revenue calculated?
Current Deferred Revenue is calculated from a company's financial statements. For PT Brigit Biofarmaka Teknologi Tbk (ISX:OBAT), the current Current Deferred Revenue is Rp0.00 Mil as of . 20. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

PT Brigit Biofarmaka Teknologi Tbk Business Description

Address Jalan Raya Tawangsari-Klaten, Rejosari, RT 01, RW 07, Kateguhan, Tawangsari, Kab. Sukoharjo, Jawa Tengah, IDN, 57561
PT Brigit Biofarmaka Teknologi Tbk is engaged in the herbal, cosmetic, and functional and botanical beverage manufacturing industry. The herbal products are used for traditional medicine products, including herbal capsules and honey, while the cosmetic products are various products for decorative and skin care. The functional and botanical beverage products are used for powdered drinks and tea.